COPD Foundation Announces Board of Directors Changes

September 07, 2018

COPD Foundation Announces Board of Directors Changes
Appointments Reflect Continued Focus on Advancing Thought Leadership in Respiratory Diseases

Washington, DC– September 7, 2018 – The COPD Foundation today announced the appointment of Byron M. Thomashow, MD, to the newly created position of chief medical officer. In addition to helping found the COPD Foundation, Dr. Thomashow, served as the chairman of the board since 2004. Michael P. Mayer, who recently served as the chairman of the human resources and finance committees for the COPD Foundation Board, has been appointed the Foundation’s newest chair.

Dr. Thomashow is a Professor of Medicine at the Columbia University Medical Center, an Attending Physician at the New York-Presbyterian Hospital and Medical Director of the Jo-Ann LeBuhn Center for Chest Disease on the Columbia campus. He was a member of the steering committee and the co-primary investigator at the Columbia site for the National Emphysema Treatment Trial and has been and remains actively involved in multiple national clinical research projects.

“As someone who knows first-hand the passion and commitment Byron has for constantly striving for better treatments and therapies for his patients, I am thrilled to welcome him to this new role” said Corinne Costa Davis, Chief Executive Officer of the COPD Foundation. “As we address the challenges presented by the fourth leading cause of death in the United States and the third leading cause of death in the world, I know that Byron’s insights and leadership capabilities will continue to propel the COPD Foundation forward in our quest to help the millions affected.”

Mr. Mayer became involved with the COPD Foundation shortly after the death of his father-in-law Richard H. Scarborough in March 2005. Mr. Mayer worked with Collin Scarborough on the creation of the Richard H. Scarborough Bronchiectasis Research Consortium and Registry which has over 2,000 registered patients in the database. Professionally, Mr. Mayer possesses over 25 years of experience with an extensive background in executive talent acquisition for clients ranging from Fortune 500 companies to early stage firms. He has spent his career helping organizations improve their leadership teams by developing and implementing strong development strategies and upgrading the quality of and talent within the company.

“I feel honored to have been selected as the new Chairman of the Board of Trustees and to follow in the footsteps of my esteemed colleague and friend Byron Thomashow. The COPD Foundation is embarking on a new period of growth and innovation and I look forward to collaborating with our stakeholders including patients, caregivers, healthcare professionals, philanthropic foundations, government organizations and our research and industry partners to address key issues within the respiratory sphere” said Mr. Mayer.

The COPD Foundation welcomes Dr. Thomashow and Mr. Mayer in their new roles.

About the COPD Foundation
The COPD Foundation’s mission is to prevent and cure chronic obstructive pulmonary disease and improve the lives of all people affected by COPD. The Foundation’s activities focus on achieving these results through research, education and advocacy programs. To learn more about the COPD Foundation, please visit